| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $39.3M | $14.9M | $8.7M |
| YoY Revenue Growth % | +162.8% | +71.8% | — |
| Gross Profit | $9.9M | $3.5M | — |
| Gross Margin % | 25.2% | 23.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.5M | -$2.4M | -$7.1M |
| Operating Margin % | -21.5% | -16.0% | -80.0% |
| Net Income (GAAP) | -$4.3M | -$1.7M | -$6.3M |
| EBITDA (Normalized) | $13.8M | -$2.0M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$9.7M | $2.2M | -$4.8M |
| Capital Expenditures (CapEx) | $27.8M | $430.6K | — |
| Free Cash Flow (FCF) | -$37.5M | $1.8M | -$4.8M |
| FCF Margin % | -80.0% | 12.0% | -54.6% |
| Return on Invested Capital (ROIC %) | -6.0% | -17.8% | — |
| Cash & Short-Term Equivalents | $30.5M | $18.2M | — |
| Total Debt (Short + Long Term) | $58.5K | $195.4K | — |
| Total Stockholders' Equity | $141.0M | $28.6M | — |